Suppression of inflammation by tumor-derived exosomes: a kind of natural liposome packaged with multifunctional proteins

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of liposome research

• Publication date

  2012-11-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/08982104.2012.710911PMID 22984881
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomics of MUC1‐containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF‐7

  2009cited by this paper
• Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models.

  2009cited by this paper
• Cell Growth Inhibition, G2/M Cell Cycle Arrest, and Apoptosis Induced by Chloroquine in Human Breast Cancer Cell Line Bcap-37

  2008cited by this paper
• MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer.

  2008cited by this paper
• Microparticles and immunomodulation in pregnancy and pre-eclampsia.

  2007cited by this paper
• Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

  2007cited by this paper
• Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling1

  2006cited by this paper
• Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.

  2005cited by this paper
• Exosomes: A new delivery system for tumor antigens in cancer immunotherapy

  2005influential reference
• Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects

  2005cited by this paper
• Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?

  2005cited by this paper
• Chemotherapy in experimental brain tumor, part 1: In vitro colorimetric MTT assay

  2004cited by this paper
• Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells.

  2004cited by this paper
• Proteomic analysis of exosomes secreted by human mesothelioma cells.

  2004cited by this paper
• Tumor exosomes expressing fas ligand mediate CD8+ T cell apoptosis

  2004cited by this paper
• ADAM10‐mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles

  2003cited by this paper
• Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.

  2003cited by this paper
• Epithelial ovarian cancer cells secrete functional Fas ligand.

  2003cited by this paper
• Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.

  2003cited by this paper
• Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles

  2002cited by this paper
• Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.

  2002cited by this paper
• Exosomes: composition, biogenesis and function

  2002cited by this paper
• Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

  2001cited by this paper
• Differential Secretion of Fas Ligand- or APO2 Ligand/TNF-Related Apoptosis-Inducing Ligand-Carrying Microvesicles During Activation-Induced Death of Human T Cells1

  2001cited by this paper
• Rapid secretion of interleukin-1β by microvesicle shedding

  2001cited by this paper
• Rapid secretion of interleukin-1beta by microvesicle shedding.

  2001cited by this paper
• Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

  2000cited by this paper
• A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry.

  1994cited by this paper
• Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).

  1987cited by this paper
• “Membrane‐Associated” Immunoglobulins in Cyst and Ascites Fluids of Ovarian Cancer Patients *

  1983cited by this paper

• The Therapeutic Potential of Extracellular Vesicles in Sepsis Management

  2025cites this paper
• Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications

  2023cites this paper
• The Role of Exosomes in Inflammatory Diseases and Tumor-Related Inflammation

  2022cites this paper
• Exosomes in cardiovascular diseases: a blessing or a sin for the mankind

  2022cites this paper
• Exosome: The Regulator of the Immune System in Sepsis

  2021cites this paper
• Proteomics analysis of Schwann cell-derived exosomes: a novel therapeutic strategy for central nervous system injury

  2019cites this paper
• Recent advances in nanomedicine for sepsis treatment.

  2018cites this paper
• Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles

  2018cites this paper
• Functional significance of exosomes applied in sepsis: A novel approach to therapy.

  2017influential citation
• Let-7a inhibits migration of melanoma cells via down-regulation of HMGA2 expression.

  2016cites this paper
• Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.

  2015cites this paper
• Exosomes in Mesenchymal Stem Cells, a New Therapeutic Strategy for Cardiovascular Diseases?

  2015cites this paper
• Analysis of exosome purification methods using a model liposome system and tunable-resistive pulse sensing

  2015cites this paper
• Liposomal drug delivery: a versatile platform for challenging clinical applications.

  2014cites this paper
• Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions

  2014cites this paper
• The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids

  2013cites this paper